There were 2,362 press releases posted in the last 24 hours and 401,707 in the last 365 days.
For Immediate Release: October 17, 2022 Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history …
For Immediate Release: October 14, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Seeks Feedback on Distributed and Point-of-Care Drug …
For Immediate Release: October 12, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a …
For Immediate Release: October 11, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: • Today, the FDA announced the launch of an independent study by the National Academies of Sciences, …
For Immediate Release: September 29, 2022 The U.S. Food and Drug Administration today approved Relyvrio (sodium phenylbutyrate/taurursodiol) to treat patients with amyotrophic lateral sclerosis (ALS), commonly referred to as Lou Gehrig’s disease. “This …
For Immediate Release: September 30, 2022 Today, the U.S. Food and Drug Administration published guidance that will help provide a pathway for infant formulas operating under enforcement discretion in the U.S. to remain on the market. This will help ensure …
For Immediate Release: September 30, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Continues Important Work on Substance Use and Overdose …
For Immediate Release: September 28, 2022 The U.S. Food and Drug Administration and the Veterans Health Administration (VHA) are announcing a collaboration intended to help accelerate American medical device innovation to further improve and benefit public …
For Immediate Release: September 28, 2022 Today, the U.S. Food and Drug Administration proposed updated criteria for when foods can be labeled with the nutrient content claim “healthy” on their packaging. This proposed rule would align the definition of …
For Immediate Release: September 27, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA released its Activities to Enhance the Safety of Imported Produce, which provides an …
For Immediate Release: September 27, 2022 Today, the U.S. Food and Drug Administration updated its COVID-19 test policy to ensure continued access to tests while encouraging the transition of these important public health tools to traditional premarket …
For Immediate Release: September 23, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Issues New Guidance to Help Facilitate Availability of …
For Immediate Release: September 23, 2022 Today, the U.S. Food and Drug Administration issued a draft guidance that, when finalized, will provide the agency’s perspective on the ethical considerations for including and protecting children in clinical …
For Immediate Release: September 20, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA alerted medical device users about a potential cybersecurity risk for the Medtronic …
For Immediate Release: September 20, 2022 Statement From: Steven M. Solomon, D.V.M., M.P.H. Director - Center for Veterinary Medicine In May 2022, FDA Commissioner Robert M. Califf, M.D., asked that I conduct an internal agency review of the agency’s …
For Immediate Release: September 20, 2022 Statement From: Robert M. Califf, M.D., MACC Commissioner of Food and Drugs - Food and Drug Administration For the past several months, the U.S. Food and Drug Administration has been working around the clock with …
For Immediate Release: September 16, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Wednesday, the FDA announced that it is taking steps to help increase the availability of novel …
For Immediate Release: September 14, 2022 Today, the U.S. Food and Drug Administration and the National Institutes of Health (NIH) announced the launch of the Critical Path for Rare Neurodegenerative Diseases (CP-RND) – a public-private partnership aimed …
For Immediate Release: September 13, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA reissued the Aug. 19, 2022, letter of authorization for Novavax COVID-19 Vaccine, …
For Immediate Release: December 09, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA, in coordination with the U.S. Department of Agriculture and the Centers for Disease …
